Re: NVS oncology webcast/ARRY There were just a couple of references to MEK162/ARRY-162 during NVS' oncology webcast today. 1. Slide 39/41 minute mark: MEK162 will be used in multiple combinations with NVS' PI3K inhibitor program in the very near future. 2. Q&A/1:11 mark: By the end of 2011 there should be enough data to understand the activity of MEK162.